The National Institute for Health and Care Excellence (NICE) has issued a warning regarding the use of blue inhalers for asthma treatment.
According to the World Health Organization (WHO), around 363 million people were living with asthma globally in 2023. The organization describes asthma as a chronic lung disease that affects people of all ages. It is caused by inflammation and tightening of the muscles around the airways, which can make breathing difficult.
NICE has now advised that relying on blue inhalers alone to manage asthma may, in some cases, lead to worsening symptoms over time.
Blue inhalers, medically known as short-acting beta2 agonists (SABA), have traditionally been used to provide quick relief from asthma symptoms. However, updated guidance in the United Kingdom suggests a change in how the condition should be managed.
In a statement, NICE explained that new recommendations encourage patients to move away from using only blue inhalers and instead consider combination inhalers. These newer treatments are designed not only to relieve immediate symptoms but also to address the underlying inflammation that contributes to asthma attacks.
Health experts say that while blue inhalers can provide fast relief, they do not treat the root cause of the condition. Over-reliance on them has been associated in medical studies with a higher risk of asthma attacks, hospital admissions, and in severe cases, serious health outcomes.
Dr. Amina Al-Yassin, a general practitioner and clinical lead at Brent Integrated Care Partnership, explained that long-term use of blue inhalers alone may not be sufficient for managing asthma effectively. She noted that patients who rely on them exclusively may be at increased risk, highlighting the importance of reviewing treatment plans with healthcare professionals.
Medical experts now increasingly recommend combination inhalers, which include both a reliever and a steroid component. These inhalers are intended to reduce inflammation while also providing symptom relief, offering a more preventative approach to asthma management.
Donna Peat, a respiratory advanced practitioner at Lancashire Teaching Hospitals NHS Trust, stated that updated guidelines represent a major shift in asthma care. She explained that the focus is now on prevention, which may help reduce the frequency and severity of asthma attacks.
Health authorities emphasize that anyone with asthma should consult a qualified healthcare provider before making any changes to their treatment plan.
This information is not medical advice. Individuals with asthma should seek guidance from a doctor or medical professional regarding their condition and treatment options.
